JB CHEMICALS & PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of JB CHEMICALS & PHARMACEUTICALS have increased by 18.69% YoY .
The Earnings Per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS has increased by 6.24 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
JB CHEMICALS & PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 506943|NSE : JBCHEPHARM]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹2,424 Cr | ₹2,043 Cr | ₹1,775 Cr | ₹1,643 Cr | ₹1,414 Cr |
| Expenses | ₹1,882 Cr | ₹1,486 Cr | ₹1,397 Cr | ₹1,337 Cr | ₹1,215 Cr |
| Operating Profit (Excl OI) | ₹543 Cr | ₹556 Cr | ₹378 Cr | ₹306 Cr | ₹199 Cr |
| Other Income | ₹40 Cr | ₹117 Cr | ₹51 Cr | ₹41 Cr | ₹55 Cr |
| Interest | ₹5.12 Cr | ₹7.24 Cr | ₹3.26 Cr | ₹4.65 Cr | ₹3.49 Cr |
| Depreciation | ₹73 Cr | ₹69 Cr | ₹66 Cr | ₹56 Cr | ₹57 Cr |
| Profit Before Tax | ₹505 Cr | ₹597 Cr | ₹349 Cr | ₹287 Cr | ₹194 Cr |
| Profit After Tax | ₹386 Cr | ₹449 Cr | ₹272 Cr | ₹194 Cr | ₹139 Cr |
| Consolidated Net Profit | ₹385 Cr | ₹448 Cr | ₹272 Cr | ₹193 Cr | ₹138 Cr |
| Earnings Per Share (Rs) | ₹52.97 | ₹49.86 | ₹57.96 | ₹35.20 | ₹24.11 |
| PAT Margin (%) | 12.54 | 15.51 | 21.96 | 15.35 | 11.80 |
| ROE(%) | 18.51 | 19.89 | 27.64 | 18.69 | 13.28 |
| ROCE(%) | 22.79 | 25.48 | 36.53 | 23.71 | 19.59 |
| Total Debt/Equity(x) | 0.23 | 0.01 | 0.02 | 0.02 | 0.02 |
Key Financials |
||
| Market Cap | : | ₹ 28,315.5 Cr |
| Revenue (TTM) | : | ₹ 3,384.8 Cr |
| Net Profit(TTM) | : | ₹ 514.1 Cr |
| EPS (TTM) | : | ₹ 33.1 |
| P/E (TTM) | : | 55.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| JB CHEMICALS & PHARMACEUTICALS | 1.9% | -1.9% | 64.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
JB CHEMICALS & PHARMACEUTICALS Revenues
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 18.69 % |
| 5 Yr CAGR | 14.43 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹2,424 Cr | 18.69 | |
| Mar2022 | ₹2,043 Cr | 15.09 | |
| Mar2021 | ₹1,775 Cr | 8.00 | |
| Mar2020 | ₹1,643 Cr | 16.23 | |
| Mar2019 | ₹1,414 Cr | - | |
JB CHEMICALS & PHARMACEUTICALS Operating Profit
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | -2.44 % |
| 5 Yr CAGR | 28.48 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹543 Cr | -2.44 | |
| Mar2022 | ₹556 Cr | 47.30 | |
| Mar2021 | ₹378 Cr | 23.45 | |
| Mar2020 | ₹306 Cr | 53.59 | |
| Mar2019 | ₹199 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -17.81 % |
| 5 Yr CAGR | 12.28 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 22.38% | -17.81 | |
| Mar2022 | 27.23% | 27.96 | |
| Mar2021 | 21.28% | 14.35 | |
| Mar2020 | 18.61% | 32.17 | |
| Mar2019 | 14.08% | - | |
JB CHEMICALS & PHARMACEUTICALS Profit After Tax
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | -13.98 % |
| 5 Yr CAGR | 29.19 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹385 Cr | -13.98 | |
| Mar2022 | ₹448 Cr | 64.66 | |
| Mar2021 | ₹272 Cr | 40.62 | |
| Mar2020 | ₹193 Cr | 39.85 | |
| Mar2019 | ₹138 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -19.15 % |
| 5 Yr CAGR | 1.53 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 12.54 % | -19.15 | |
| Mar2022 | 15.51 % | -29.37 | |
| Mar2021 | 21.96 % | 43.06 | |
| Mar2020 | 15.35 % | 30.08 | |
| Mar2019 | 11.8 % | - | |
JB CHEMICALS & PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 6.24 % |
| 5 Yr CAGR | 21.75 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹53 | 6.24 | |
| Mar2022 | ₹50 | -13.98 | |
| Mar2021 | ₹58 | 64.66 | |
| Mar2020 | ₹35 | 46.00 | |
| Mar2019 | ₹24 | - | |
JB CHEMICALS & PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | -10.56 % |
| 5 Yr CAGR | 3.86 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 22.79% | -10.56 | |
| Mar2022 | 25.48% | -30.25 | |
| Mar2021 | 36.53% | 54.07 | |
| Mar2020 | 23.71% | 21.03 | |
| Mar2019 | 19.59% | - | |
JB CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹1,824.5 |
| Current MarketCap | : | ₹ 28,315.5 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JB CHEMICALS & PHARMACEUTICALS | 1.9% |
-1.9% |
64.7% |
| SENSEX | 1.3% |
2.6% |
24% |
JB CHEMICALS & PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
| S&P BSE 250 SMALLCAP | 2.5% | 12.8% | 64.9% |
| S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
| S&P BSE 400 MIDSMALLCAP | 1.9% | 9.9% | 59.4% |
| S&P BSE SMALLCAP SELECT INDEX | 1.6% | 10.1% | 46% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 | 2.8% | 13.8% | 71.1% |
| NIFTY FREE SMALL 100 | 2.5% | 14.8% | 78.4% |
| NIFTY MID SMALL400 | 2.1% | 10.7% | 62.3% |
| NIFTY500 MULTICAP 50:25:25 | 1.8% | 7.7% | 48.1% |
| NIFTY 500 | 1.5% | 5.7% | 39.5% |
You may also like the below Video Courses
FAQ about JB CHEMICALS & PHARMACEUTICALS Financials
How the annual revenues of JB CHEMICALS & PHARMACEUTICALS have changed ?
The Revenues of JB CHEMICALS & PHARMACEUTICALS have increased by 18.69% YoY .
How the Earnings per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS has increased by 6.24 % YoY .
Check out Intrinsic Value of Peers of JB CHEMICALS & PHARMACEUTICALS
Compare Stock Analytics of Peers of JB CHEMICALS & PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
